Thymic Epithelial Stem Cell Isolation and Expansion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current understanding of postnatal thymic epithelial stem cells and mechanisms for thymus homeostasis and repair are limited, leading to a lack of therapeutic strategies for diseases associated with thymic dysfunction.
Innovation Solution
Identification and characterization of thymic epithelial stem cells (TESCs) through high-resolution single-cell analysis, along with methods for their isolation, culture, and differentiation into various thymic epithelial cell types.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If high-resolution single-cell analysis and prospective isolation methods are used to identify TESCs, then measurement precision and manufacturing precision are improved, but device complexity and difficulty of detecting and measuring increase
Solution Approach 1:
The patent segments the complex task of TESC identification into multiple sequential steps: initial enrichment using BCAM and CD49F markers, followed by sorting using CD90 and CD24 markers. This multi-stage segmentation approach breaks down the difficult single-cell analysis into manageable steps, improving measurement precision while making the process more tractable
Solution Approach 2:
The patent applies preliminary action by performing initial cell enrichment and selection using BCAMposCD49Fpos markers before conducting the more complex CD90posCD24neg sorting. This preliminary step reduces the complexity of subsequent measurements by pre-concentrating the target cell population, thereby improving overall measurement precision without proportionally increasing difficulty
2Productivity
If TESCs are cultured under conditions for long-term expansion, then productivity is improved, but maintaining stemness and preventing differentiation becomes more difficult
Solution Approach 1:
The patent employs feedback mechanisms by monitoring TESC proliferation and differentiation markers during culture expansion. Growth factors and niche signals are adjusted based on real-time assessment of cell state, allowing long-term expansion while maintaining stemness through dynamic control that responds to changing cell conditions
Solution Approach 2:
The patent utilizes parameter changes by modifying culture conditions including growth factor concentrations, substrate composition, and oxygen levels to balance proliferation and stemness maintenance. These dynamic parameter adjustments enable long-term expansion while preventing premature differentiation, resolving the contradiction between productivity and compositional stability
3Adaptability or versatility
If TESCs are differentiated into specific thymic epithelial cell types, then adaptability is improved, but loss of stemness and self-renewal capacity occurs
Solution Approach 1:
The patent applies dynamics by creating a flexible differentiation system where TESCOs can transition between undifferentiated and differentiated states based on culture conditions. By using reversible differentiation protocols and maintaining some cells in an undifferentiated state while differentiating others, the system achieves adaptability for generating multiple cell types while preserving the self-renewal capacity of the stem cell pool
Data Source
AI summary
The present invention relates to a newly identified population of thymic epithelial stem cells, methods for their isolation, culture and differentiation, and uses of the cells, in particular their use in therapy, creation of therapeutic thymic constructs and drug screening.